Hemorheological background of acetylsalicylic acid resistance - PubMed (original) (raw)
Affiliations
- PMID: 18239256
Hemorheological background of acetylsalicylic acid resistance
Gergely Feher et al. Clin Hemorheol Microcirc. 2008.
Abstract
Background: Pathologic hemorheological parameters and increased platelet aggregation in association with other risk factors significantly increase the possibility of the development of ischemia. Acetylsalicylic acid (ASA) is an effective antithrombotic agent, which prevents a variety of cardiovascular diseases.
Objectives: The aim of our present study was to compare the hemorheological parameters of patients with effective platelet inhibition by ASA to those with ineffective one.
Methods: 2045 patients taking 100 mg ASA daily were involved in our study (1255 males, mean age: 63+/-11 yrs, 790 females, mean age: 63+/-12 yrs). To exclude the effect of risk profile, previous diseases and medication, 323 patients (197 males, mean age 60+/-13 yrs and 126 females, mean age 60+/-12 yrs) were selected from the examined group with matching parameters. Blood was taken after an overnight fast between 8:00 and 9:00 a.m. Platelet aggregation was measured in Carat TX-4 optical platelet aggregometer. Blood hematocrit was measured by Heraeus microhematocrit centrifuge and red blood cell aggregation was detected by Myrenne aggregometer. Plasma fibrinogen was measured by Clauss' method. Plasma and whole blood viscosities were measured in Hevimet 40 capillary viscosimeter.
Results: Patients with effective ASA inhibition had significantly lower plasma fibrinogen level (p<0.05) and red blood cell aggregation values both in the heterogenous and the selected populations (p<0.01). The other hemorheological parameters were not statistically different in the two groups.
Conclusion: The background of ineffective ASA medication has not yet been fully elucidated. Higher fibrinogen concentration increases red blood cell aggregation and can also result in increased platelet aggregation. Thus, increased plasma fibrinogen level may play an important role in the in vitro and in vivo platelet resistance to ASA.
Similar articles
- Hemorheological parameters and aging.
Feher G, Koltai K, Kesmarky G, Szapary L, Juricskay I, Toth K. Feher G, et al. Clin Hemorheol Microcirc. 2006;35(1-2):89-98. Clin Hemorheol Microcirc. 2006. PMID: 16899911 - Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L. Feher G, et al. Phytomedicine. 2009 Mar;16(2-3):111-7. doi: 10.1016/j.phymed.2008.10.014. Epub 2009 Jan 8. Phytomedicine. 2009. PMID: 19135345 Clinical Trial. - Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes.
Marton Z, Horvath B, Alexy T, Kesmarky G, Gyevnar Z, Czopf L, Habon T, Kovacs L, Papp E, Mezey B, Roth E, Juricskay I, Toth K. Marton Z, et al. Clin Hemorheol Microcirc. 2003;29(2):81-94. Clin Hemorheol Microcirc. 2003. PMID: 14610303 - Rheological abnormalities and thromboembolic complications in heart disease: spontaneous echo contrast and red cell aggregation.
Kwaan HC, Sakurai S, Wang J. Kwaan HC, et al. Semin Thromb Hemost. 2003 Oct;29(5):529-34. doi: 10.1055/s-2003-44559. Semin Thromb Hemost. 2003. PMID: 14631552 Review. - [Rheologic modifications induced by heparin therapy. Capillary blood viscosity, erythrocyte deformability, aggregation index].
Achilli E, Cortinovis A, Ardemagni P, Crippa A. Achilli E, et al. Minerva Cardioangiol. 1999 Apr;47(4):95-119. Minerva Cardioangiol. 1999. PMID: 10416313 Review. Italian.
Cited by
- Effects of aspirin on rheological properties of erythrocytes in vitro.
Elblbesy MA, Hereba AR, Shawki MM. Elblbesy MA, et al. Int J Biomed Sci. 2012 Sep;8(3):188-93. Int J Biomed Sci. 2012. PMID: 23675272 Free PMC article. - Clinical importance of aspirin and clopidogrel resistance.
Feher G, Feher A, Pusch G, Koltai K, Tibold A, Gasztonyi B, Papp E, Szapary L, Kesmarky G, Toth K. Feher G, et al. World J Cardiol. 2010 Jul 26;2(7):171-86. doi: 10.4330/wjc.v2.i7.171. World J Cardiol. 2010. PMID: 21160749 Free PMC article. - Heparin-like effect of a dual antiplatelet and anticoagulant (APAC) agent on red blood cell deformability and aggregation in an experimental model.
Matrai AA, Varga A, Bedocs-Barath B, Vanyolos E, Orban-Kalmandi R, Loczi L, Bagoly Z, Jouppila A, Lassila R, Nemeth N, Deak A. Matrai AA, et al. J Thromb Thrombolysis. 2024 Dec;57(8):1329-1338. doi: 10.1007/s11239-024-03040-8. Epub 2024 Sep 4. J Thromb Thrombolysis. 2024. PMID: 39231863 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources